The antimicrobial susceptibility patterns of diabetic foot ulcers in the South African public healthcare sector

Authors

  • M J Turner Department of Pharmacy and Pharmacology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
  • S Leigh-de Rapper Department of Pharmacy and Pharmacology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
  • T P Mokoena Department of Podiatry, Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg, South Africa
  • S van Vuuren Department of Pharmacy and Pharmacology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa

DOI:

https://doi.org/10.7196/SAMJ.2024.v114i6.1131

Keywords:

antimicrobial, foot ulcer, diabetic, antimicrobial resistance, susceptibility testing

Abstract

Background. Diabetic foot syndrome is defined as the presence of a diabetic foot ulcer (DFU) associated with neuropathy, peripheral artery disease and infection. While the use of antimicrobials in the treatment of DFU infection remains a mainstay, the choice of antimicrobial remains problematic owing to the presence of multidrug-resistant polymicrobial infections. In the South African public healthcare sector, the treatment of DFUs is based on the Standard Treatment Guidelines (STGs) and the Essential Drug List. These guidelines are developed using evidence-based medicine and are based on global susceptibility patterns rather than local susceptibility data, and may not provide the most appropriate treatment options.

Objectives. To determine the antimicrobial susceptibility patterns of DFUs isolated from patients visiting selected Gauteng provincial public hospitals in order to determine a clinically effective treatment protocol for the management of these infections.

Methods. Sample swabs were taken from 51 DFUs using the Levine method. Each sample swab was spread onto blood agar plates, and thereafter individual pathogens were isolated. The antimicrobial susceptibility patterns of all isolated pathogens were determined using zone of inhibition measurements. Pathogens were grouped according to macromorphological characteristics as well as susceptibility patterns, and a representative isolate from each group was then identified.

Results. A total of 51 DFU ulcer swabs from 45 patients were included in the study. From the sample swabs, a total of 445 pathogens were isolated. The most effective antimicrobial was found to be gentamicin, followed by ciprofloxacin. Amoxicillin/clavulanic acid, the first-line treatment according to the STGs, was found to be ineffective for many of the isolated pathogens. The most commonly isolated pathogens were Proteus mirabilis, Enterococcus faecalis and Pseudomonas aeruginosa.

Conclusion. These findings demonstrate the urgent need to reassess the STGs and base treatment plans on local epidemiological data. This study provides valuable data on common causative pathogens in DFU infections, as well as the resistance patterns of these pathogens, forming a baseline on which to base future DFU treatment plans.

References

International Diabetes Federation. IDF Diabetes Atlas. 10th ed. International Diabetes Federation, 2021. https://idf.org/e-library/epidemiology-research/diabetes-atlas.html (accessed 26 October 2022). 2. Volmer-Thole M, Lobmann R. Neuropathy and diabetic foot syndrome. Int J Mol Sci 2016;17(6):917.

https://doi.org/10.3390/ijms17060917

Papatheodorou K, Banach M, Bekiari E, Rizzo M, Edmonds M. Complications of diabetes 2017. J Diabetes Res 2018:3086167. https://doi.org/10.1155/2018/3086167

Van Netten JJ, Bus SA, Apelqvist J, et al. Definitions and criteria for diabetic foot disease. Diabetes Metab Res Rev 2020;36(S1):e3268. https://doi.org/10.1002/dmrr.3268

Lavery LA, Armstrong DG, Wunderlich RP, Mohler MJ, Wendel CS, Lipsky BA. Risk factors for foot infections in individuals with diabetes. Diabetes Care 2006;29(6):1288-1293. https://doi.org/10.2337/ dc05-2425

Chastain CA, Klopfenstein N, Serezani CH, Aronoff DM. A clinical review of diabetic foot infections. Clin Podiatr Med Surg 2019;36(3):381-395. https://doi.org/10.1016/j.cpm.2019.02.004

Rotchford AP, Rotchford KM. Diabetes in rural South Africa – an assessment of care and complications. S Afr Med J 2002;92(7):536-541.

Zhang P, Lu J, Jing Y, Tang S, Zhu D, Bi Y. Global epidemiology of diabetic foot ulceration: A systematic review and meta-analysis. Ann Med 2017;49(2):106-116. https://doi.org/10.1080/07853890.2016.123 1932

Mothabeng T, Ngcobo T, Singh N, et al. The use of epidermal growth factor in diabetic foot ulcers in South Africa. WHSA 2022;15(1):16-21. https://doi.org/10.10520/ejc-mp_whsa_v15_n1_a5

Hobizal KB, Wukich DK. Diabetic foot infections: Current concept review. Diabet Foot Ankle 2012;3(1):18409. https://doi.org/10.3402/dfa.v3i0.18409

Noor S, Zubair M, Ahmad J. Diabetic foot ulcer – a review on pathophysiology, classification and microbial etiology. Diabetes Metab Syndr 2015;9(3):192-199. https://doi.org/10.1016/j.dsx.2015.04.007

Malepati S, Vakamudi P, Kandati J, Satish S. Bacteriological study of diabetic foot ulcer according to Wagner’s classification: A one-year study. Int Surg J 2018;5(1): 98-104. https://doi.org/10.18203/2349-

isj20175534

Sadeghpour Heravi F, Zakrzewski M, Vickery K, D GA, Hu H. Bacterial diversity of diabetic foot ulcers: Current status and future prospectives. J Clin Med 2019;8(11):1935. https://doi.org/10.3390/ jcm8111935

Pitocco D, Spanu T, Di Leo M, et al. Diabetic foot infections: A comprehensive overview. Eur Rev Med Pharmacol Sci 2019;23(Suppl 2):S26-S37. https://doi.org/10.26355/eurrev_201904_17471

Lipsky BA, Aragón-Sánchez J, Diggle M, et al. IWGDF guidance on the diagnosis and management of foot infections in persons with diabetes. Diabetes Metab Res Rev 2016;32(S1):45-74. https://doi. org/10.1002/dmrr.2699

1Kwon KT, Armstrong DG. Microbiology and antimicrobial therapy for diabetic foot infections. Infect Chemother 2018;50(1):11-20. https://doi.org/10.3947/ic.2018.50.1.11

Lipsky BA, Berendt AR, Cornia PB, et al. 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis 2012;54(12):e132-e173. https://doi.org/10.1093/cid/cis346

Lavery LA, Davis KE, Berriman SJ, et al. WHS guidelines update: Diabetic foot ulcer treatment guidelines. Wound Repair Regen 2016;24(1):112-126. https://doi.org/10.1111/wrr.12391

Del Core MA, Ahn J, Lewis RB, Raspovic KM, Lalli TAJ, Wukich DK. The evaluation and treatment of diabetic foot ulcers and diabetic foot infections. FAO 2018;3(3):1-11. https://doi. org/10.1177/2473011418788864

Hassan MA, Tamer TM, Rageh AA, Abou-Zeid AM, Abd El-Zaher EHF, Kenawy E-R. Insight into multidrug-resistant microorganisms from microbial infected diabetic foot ulcers. Diabetes Metab Syndr 2019;13(2):1261-1270. https://doi.org/10.1016/j.dsx.2019.01.044

Kagwa GH, Amugune, BK, Menge TB, Nyamu, DG. Antimicrobial susceptibility of bacteria that infect diabetic foot ulcers at Kenyatta National Hospital, Kenya. Afr J Phamacol Ther 2018;7(2):34-40.

Ogba OM, Nsan E, Eyam ES. Aerobic bacteria associated with diabetic foot ulcers and their susceptibility pattern. Biomed Dermatol 2019;3(1):1-6. https://doi.org?10.1186/s41702-019-0039-x

Abahamye A. Antibiotic stewardship: Factors influencing the choice and outcomes of antimicrobial

therapy in a resource-limited, rural, public hospital in uMkhanyakude District, KwaZulu-Natal, South

Africa: Pre-intervention phase: Review. SAPJ 2016;83(8):35-44. https://doi.org/10.10520/EJC196850

National Department of Health, South Africa. Primary Healthcare Standard Treatment Guideline and

Essential Medicine List. 7th ed. Pretoria: NDoH, 2020.

urner MJ, van Vuuren S, Leigh-deRapper S. Analysing patient factorsand treatment impact on diabetic

footulcers in South Africa. S Afr J Sci.2024;120(3/4); 1-9. https://doi.org/10.17159/sajs.2024/16301

Levine NS, Lindberg RB, Mason AD Jr, Pruitt BA Jr. The quantitative swab culture and smear: A quick, simple method for determining the number of viable aerobic bacteria on open wounds. J Trauma

;16(2):89-94.

Cross HH. Obtaining a wound swab culture specimen. Nursing 2014;44(7):68-69. https://doi.

org/10.1097/01.NURSE.0000446645.33489.2e

Steer JA, Papini RPG, Wilson APR, McGrouther DA, Parkhouse N. Quantitative microbiology in the management of burn patients. I. Correlation between quantitative and qualitative burn wound biopsy culture and surface alginate swab culture. Burns 1996;22(3):173-176. https://doi.org/10.1016/0305- 4179(95)00116-6

Angel DE, Lloyd P, Carville K, Santamaria N. The clinical efficacy of two semi-quantitative wound- swabbing techniques in identifying the causative organism(s) in infected cutaneous wounds. Int Wound J 2011;8(2):176-185. https://doi.org/10.1111/j.1742-481X.2010.00765.x

Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. 32nd ed. CLSI supplement M100. Clinical and Laboratory Standards Institute; 2022

Breakwell DP, Macdonald B, Woolverton CJ, Smith KC, Robison RA. Colony morphology protocol. American Society for Microbiology 2007;1-7.

Lalitha MK. Manual on antimicrobial susceptibility testing. Performance Standards for Antimicrobial Testing: Twelfth Informational Supplement 2004;56238:454-456

Miyan Z, Fawwad A, Sabir R, Basit A. Microbiological pattern of diabetic foot infections at a tertiary care center in a developing country. J Pak Med Assoc 2017;67(5):665-669.

Goh TC, Bajuri MY, Nadarajah CS, Abdul Rashid AH, Baharuddin S, Zamri KS. Clinical and bacteriological profile of diabetic foot infections in a tertiary care. J Foot Ankle Res 2020;13(1):36. https://doi.org/10.1186/s13047-020-00406-y

Benwan KA, Mulla AA, Rotimi VO. A study of the microbiology of diabetic foot infections in a teaching hospital in Kuwait. J Infect Public Health 2012;5(1):1-8. https://doi.org/10.1016/j.jiph.2011.07.004

Sannathimmappa MB, Nambiar V, Aravindakshan R, et al. Diabetic foot infections: Profile and

antibiotic susceptibility patterns of bacterial isolates in a tertiary care hospital of Oman. J Educ Health

Promot 2021;10:254. https://doi.org/10.4103/jehp.jehp_1552_20

Gupta S SK, Bhat IY, Raina AS. The spectrum of diabetic foot ulcer: A prospective study in a tertiary

hospital. J Adv Med Dent Sci Res 2022;10(2):60-64. https://doi.org/10.21276/jamdsr

Rhoads DD, Wolcott RD, Sun Y, Dowd SE. Comparison of culture and molecular identification of bacteria in chronic wounds. Int J Molecular Sci 2012;13(3):2535-2550. https://doi.org/10.3390/

ijms13032535

Naude L. The impact of COVID-19 on wound care provision in South Africa: A personal account. Wounds Int 2020;11(3):17-19.

Allen ML, van der Does AMB, Gunst C. Improving diabetic foot screening at a primary care clinic: A quality improvement project: Original research. Afr J Prim Health Care Fam Med 2016;8(1):1-9. https://doi.org/10.4102/phcfm.v8i1.955

Zipfel B, Dembskey N. COVID-19 pandemic and the South African podiatrist. Preprints 2020;1-10.

https://doi.org/10.20944/preprints202009.0425.v1

Sanchez CA, Niño ME, Calderon M, García LF, Sierra D. Microbiota of diabetic foot infections in a University Hospital in Bogotá, Colombia. Foot 2022;52:101867. https://doi.org/10.1016/j.foot.2021.101867 43. Xie X, Bao Y, Ni L, et al. Bacterial profile and antibiotic resistance in patients with diabetic foot ulcer

in Guangzhou, Southern China: Focus on the differences among different Wagner’s grades, IDSA/

IWGDF grades, and ulcer types. Int J Endo 2017;2017:8694903. https://doi.org/10.1155/2017/8694903 44. Akwah L, Fokunang C, Nukenine E, et al. Bacteriology of diabetic foot ulcers with reference to multidrug resistance strains at the Yaounde Central Hospital (Cameroon). JDMP 2015;1(4):53-58https://doi.

org/10.11648/j.jdmp.20150104.11

Mohammuddunnobi TJ, AA Amin. Microbiological study of diabetic foot ulcer. Anwer Anwer Khan Mod Med Coll J 2019;10(1):50-55.

Macdonald KE, Boeckh S, Stacey HJ, Jones JD. The microbiology of diabetic foot infections: A meta- analysis. BMC Infec Dis 2021;21(1):770. https://doi.org/10.1186/s12879-021-06516-7

Smith K, Collier A, Townsend EM, et al. One step closer to understanding the role of bacteria in diabetic foot ulcers: Characterising the microbiome of ulcers. BMC Microbiol 2016;16(1):54. https:// doi.org/10.1186/s12866-016-0665-z

Patel BK, Patel KH, Huang RY, Lee CN, Moochhala SM. The gut-skin microbiota axis and its role in diabetic wound healing: A review based on current literature. Int J Mol Sci 2022;23(4):2375. https:// doi.org/10.3390/ijms23042375

Mohammed Aldawish MA. Occurence of common pathogens among diabetic foot ulcer patients in Saudi Arabia. Endocr Pract 2018;24:42. https://www.proquest.com/scholarly-journals/occurrence-common- pathogen-among-diabetic-foot/docview/2050591705/se-2?accountid=15083 (accesses 20 May 2024).

Dinh TL, Veves A. A review of the mechanisms implicated in the pathogenesis of the diabetic foot. Int J Low Extrem Wounds 2005;4(3):154-159. https://doi.org/10.1177/1534734605280130

Singh AK, Yeola M, Singh N, Damke S. A study on diabetic foot ulcers in Central rural India to formulate empiric antimicrobial therapy. J Family Med Prim Care 2020;9(8):4216-4222. https://doi. org/10.4103/jfmpc.jfmpc_700_20

Sani SB, Musa K, Muhammad B. Drug susceptibility pattern of bacterial pathogens associated with diabetic foot ulcers of patients in Kano North-Western Nigeria. UJMR 2020;4(2):83-87. https://doi. org/10.47430/ujmr.1942.014

Appapalam ST, Muniyan A, Mohan KV, Panchamoorthy R. A Study on isolation, characterisation, and exploration of multiantibiotic-resistant bacteria in the wound site of diabetic foot ulcer patients. Int J Low Extrem Wounds 2021;20(1):6-14. https://doi.org/10.1177/1534734619884430

Pontes DG, Silva I, Fernandes JJ, et al. Microbiologic characteristics and antibiotic resistance rates of diabetic foot infections. Rev Col Bras Cir 2020;47:e20202471. https://doi.org/10.1590/0100- 6991e-20202471

Lipsky BA. Empirical therapy for diabetic foot infections: Are there clinical clues to guide antibiotic selection? Clin Microbiol Infect 2007;13(4):351-353. https://doi.org/10.1111/j.1469-0691.2007.01697

Srivastava P, Sivashanmugam K. Combinatorial drug therapy for controlling Pseudomonas aeruginosa and its association with chronic condition of diabetic foot ulcer. Int J Low Extrem Wounds 2020;19(1):7-20. https://doi.org/10.1177/1534734619873785

Wasnik RN, Marupuru S, Mohammed ZA, Rodrigues GS, Miraj SS. Evaluation of antimicrobial therapy and patient adherence in diabetic foot infections. Clin Epidemiol Glob Health 2019;7(3):283- 287. http://doi.org/10.1016/j.cegh.2018.10.005

Hand R, Manning L, Ritter JC, et al. Antimicrobial stewardship opportunities among inpatients with diabetic foot infections: Microbiology results from a tertiary hospital multidisciplinary unit. Intern Med J 2019;49(4):533-536. https://doi.org/10.1111/imj.14251

Kruszewska K, Wesolowska-Gorniak K, Czarkowska-Paczek B. A comparative analysis of antibiotic usage in diabetic foot infections against healing time. J Foot Ankle Surg 2021;60(5):902-907. https:// doi.org/10.1053/j.jfas.2020.05.024

Downloads

Published

2024-05-31

Issue

Section

Research

How to Cite

1.
Turner MJ, Leigh-de Rapper S, Mokoena TP, van Vuuren S. The antimicrobial susceptibility patterns of diabetic foot ulcers in the South African public healthcare sector. S Afr Med J [Internet]. 2024 May 31 [cited 2024 Dec. 9];114(6):e1131. Available from: https://samajournals.co.za/index.php/samj/article/view/1131

Similar Articles

1-10 of 44

You may also start an advanced similarity search for this article.